Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Influenza and Other Respiratory Viruses|February 18, 2025
Cardiac Characteristics of Hospitalized Influenza Patients: An Interim Analysis From the FluHeart StudyKristoffer Grundtvig Skaarup, Filip Soeskov Davidovski, Emil Durukan, et al.
Cardiology|December 1, 2022
Cardiac Characteristics of the First Two Waves of COVID-19 in Denmark and the Prognostic Value of Echocardiography: The ECHOVID-19 StudyJacob Christensen, Filip Søskov Davidoski, Kristoffer Grundtvig Skaarup, et al.
Respiratory Care|November 24, 2021
Lung Ultrasound Findings Associated With COVID-19 ARDS, ICU Admission, and All-Cause MortalityCaroline Espersen, Elke Platz, Kristoffer Grundtvig Skaarup, et al.
Journal of the American Heart Association|September 21, 2022
Myocardial Work in Patients Hospitalized With COVID-19: Relation to Biomarkers, COVID-19 Severity, and All-Cause MortalityFlemming Javier Olsen, Mats Christian Højbjerg Lassen, Kristoffer Grundtvig Skaarup, et al.
Journal of Ultrasound|July 2, 2021
Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 studyKristoffer Grundtvig Skaarup, Mats Christian Højbjerg Lassen, Caroline Espersen, et al.
The New England Journal of Medicine|September 1, 2025
High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older AdultsNiklas Dyrby Johansen, Daniel Modin, Matthew M Loiacono, et al.
Circulation. Heart Failure|August 30, 2025
High-Dose vs. Standard-Dose Influenza Vaccine in Heart Failure: A Prespecified Analysis of the DANFLU-2 TrialKristoffer Grundtvig Skaarup, Niklas Dyrby Johansen, Daniel Modin, et al.
JAMA Internal Medicine|January 12, 2026
High-Dose vs Standard-Dose Influenza Vaccine in Older Adults With Diabetes: A Secondary Analysis of the DANFLU-2 Randomized Clinical TrialAnne Bjerg Nielsen, Niklas Dyrby Johansen, Daniel Modin, et al.
JAMA Cardiology|August 30, 2025
High-Dose vs Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: A Prespecified Secondary Analysis of the DANFLU-2 Randomized Clinical TrialNiklas Dyrby Johansen, Daniel Modin, Matthew M Loiacono, et al.
European Heart Journal|August 30, 2025
High-dose vs. standard-dose inactivated influenza vaccine and cardiovascular outcomes in persons with or without pre-existing atherosclerotic cardiovascular disease: the DANFLU-2 trialManan Pareek, Niklas Dyrby Johansen, Daniel Modin, et al.
Pageof 3